New horizons for newborn brain protection: Enhancing endogenous neuroprotection

10.1136/archdischild-2014-306284

Saved in:

Bibliographic Details
Main Authors:	Hassell, K.J, Ezzati, M, Alonso-Alconada, D, Hausenloy, D.J, Robertson, N.J
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Published:	BMJ Publishing Group 2020
Subjects:	cannabinoid erythropoietin melatonin neuroprotective agent brain injury brain protection human hypothermia induced hypothermia ischemic postconditioning meta analysis (topic) neuroprotection newborn pathogenesis patient safety phase 1 clinical trial (topic) phase 2 clinical trial (topic) phase 3 clinical trial (topic) priority journal randomized controlled trial (topic) reperfusion Review adverse effects Asphyxia Neonatorum brain drug effects Hypoxia-Ischemia, Brain pathophysiology procedures Brain Cannabinoids Erythropoietin Humans Hypothermia, Induced Infant, Newborn Melatonin Neuroprotection Neuroprotective Agents
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/179641
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-179641
record_format	dspace
spelling	sg-nus-scholar.10635-1796412023-08-07T09:13:30Z New horizons for newborn brain protection: Enhancing endogenous neuroprotection Hassell, K.J Ezzati, M Alonso-Alconada, D Hausenloy, D.J Robertson, N.J DUKE-NUS MEDICAL SCHOOL cannabinoid erythropoietin melatonin cannabinoid erythropoietin melatonin neuroprotective agent brain injury brain protection human hypothermia induced hypothermia ischemic postconditioning meta analysis (topic) neuroprotection newborn pathogenesis patient safety phase 1 clinical trial (topic) phase 2 clinical trial (topic) phase 3 clinical trial (topic) priority journal randomized controlled trial (topic) reperfusion Review adverse effects Asphyxia Neonatorum brain drug effects Hypoxia-Ischemia, Brain neuroprotection pathophysiology procedures Asphyxia Neonatorum Brain Cannabinoids Erythropoietin Humans Hypothermia, Induced Hypoxia-Ischemia, Brain Infant, Newborn Melatonin Neuroprotection Neuroprotective Agents 10.1136/archdischild-2014-306284 Archives of Disease in Childhood: Fetal and Neonatal Edition 100 6 F541-F551 2020-10-23T08:09:04Z 2020-10-23T08:09:04Z 2015 Review Hassell, K.J, Ezzati, M, Alonso-Alconada, D, Hausenloy, D.J, Robertson, N.J (2015). New horizons for newborn brain protection: Enhancing endogenous neuroprotection. Archives of Disease in Childhood: Fetal and Neonatal Edition 100 (6) : F541-F551. ScholarBank@NUS Repository. https://doi.org/10.1136/archdischild-2014-306284 1359-2998 https://scholarbank.nus.edu.sg/handle/10635/179641 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BMJ Publishing Group Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	cannabinoid erythropoietin melatonin cannabinoid erythropoietin melatonin neuroprotective agent brain injury brain protection human hypothermia induced hypothermia ischemic postconditioning meta analysis (topic) neuroprotection newborn pathogenesis patient safety phase 1 clinical trial (topic) phase 2 clinical trial (topic) phase 3 clinical trial (topic) priority journal randomized controlled trial (topic) reperfusion Review adverse effects Asphyxia Neonatorum brain drug effects Hypoxia-Ischemia, Brain neuroprotection pathophysiology procedures Asphyxia Neonatorum Brain Cannabinoids Erythropoietin Humans Hypothermia, Induced Hypoxia-Ischemia, Brain Infant, Newborn Melatonin Neuroprotection Neuroprotective Agents
spellingShingle	cannabinoid erythropoietin melatonin cannabinoid erythropoietin melatonin neuroprotective agent brain injury brain protection human hypothermia induced hypothermia ischemic postconditioning meta analysis (topic) neuroprotection newborn pathogenesis patient safety phase 1 clinical trial (topic) phase 2 clinical trial (topic) phase 3 clinical trial (topic) priority journal randomized controlled trial (topic) reperfusion Review adverse effects Asphyxia Neonatorum brain drug effects Hypoxia-Ischemia, Brain neuroprotection pathophysiology procedures Asphyxia Neonatorum Brain Cannabinoids Erythropoietin Humans Hypothermia, Induced Hypoxia-Ischemia, Brain Infant, Newborn Melatonin Neuroprotection Neuroprotective Agents Hassell, K.J Ezzati, M Alonso-Alconada, D Hausenloy, D.J Robertson, N.J New horizons for newborn brain protection: Enhancing endogenous neuroprotection
description	10.1136/archdischild-2014-306284
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Hassell, K.J Ezzati, M Alonso-Alconada, D Hausenloy, D.J Robertson, N.J
format	Review
author	Hassell, K.J Ezzati, M Alonso-Alconada, D Hausenloy, D.J Robertson, N.J
author_sort	Hassell, K.J
title	New horizons for newborn brain protection: Enhancing endogenous neuroprotection
title_short	New horizons for newborn brain protection: Enhancing endogenous neuroprotection
title_full	New horizons for newborn brain protection: Enhancing endogenous neuroprotection
title_fullStr	New horizons for newborn brain protection: Enhancing endogenous neuroprotection
title_full_unstemmed	New horizons for newborn brain protection: Enhancing endogenous neuroprotection
title_sort	new horizons for newborn brain protection: enhancing endogenous neuroprotection
publisher	BMJ Publishing Group
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/179641
_version_	1779152524261982208

New horizons for newborn brain protection: Enhancing endogenous neuroprotection

Similar Items